Skip to main content
PODD logo

Insulet Corporation

PODDNASDAQHealthcareMedical Devices

$141.10Today:- (-)1Y −56.44%

As of Oct 16, 2026 close

Market cap
$9.63B
P/E (TTM)
25.66
Forward P/E
16.34
Dividend yield
-
52-week range
$126.40$354.88
Volume (live)
-
Avg. volume (3M)
1.61M

Insulet (PODD) Income Statement

Insulet reported revenue of $2.71B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 30.7% from $2.07B a year earlier. Net income was $247.10M, down 40.9% year over year, a net margin of 9.1%. Gross margin was 71.6% and operating margin 17.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $801.70M, up 23.5% from the same quarter a year earlier.

Insulet Income Statement Analysis

Values in billions USD

Scroll to see more
Insulet Corporation income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue2.712.071.701.311.100.900.740.560.46
Cost of Revenue0.770.630.540.500.350.320.260.190.19
Gross Profit1.941.451.160.810.750.580.480.370.28
Operating Expenses
Research & Development0.300.220.210.180.160.150.130.090.07
Selling, General & Administrative1.170.920.730.590.470.380.300.250.21
Operating Expenses1.471.140.940.770.630.530.430.340.28
Operating Income0.470.310.220.040.130.050.050.03-0.01
Other Income/Expense
Interest Income0.030.040.030.010.000.000.000.010.00
Interest Expense-0.060.040.040.040.060.050.030.020.02
Other Income/Expense-0.13-0.01-0.010.00-0.11-0.04-0.04-0.02-0.02
Income
Income Before Tax0.340.300.210.010.020.010.010.01-0.03
Income Tax Expense-0.09-0.120.010.010.000.000.000.000.00
Net Income0.250.420.210.000.020.010.010.00-0.03
Net Income - Continuous Operations0.250.420.210.000.020.010.010.00-0.03
Net Income - Discontinued Operations---------
EBITDA0.560.420.320.110.140.110.070.050.01
EBIT0.470.340.250.050.13----
Depreciation & Amortization0.090.080.070.060.060.060.030.020.01
Earnings Per Share
Basic EPS4.006.003.00------
Diluted EPS3.006.003.00------
Basic Shares Outstanding0.070.070.070.070.070.060.060.060.06
Diluted Shares Outstanding0.070.070.070.070.070.070.060.060.06

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Insulet Financial Statements

What was Insulet's revenue in fiscal 2025?

Insulet reported revenue of $2.71B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 30.7% from $2.07B a year earlier.

Is Insulet profitable?

Yes. Insulet earned net income of $247.10M in fiscal 2025, a net margin of 9.1%. In fiscal 2024 it earned $418.30M.

What is Insulet's operating margin?

Insulet's operating income was $473.80M on revenue of $2.71B in fiscal 2025, an operating margin of 17.5%, compared with 14.9% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition